Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
GOODMAN JESSE
Director at Intellia Therapeutics. Filing since 30 Jun 2025.
CIK 0001756929
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
1 Jul 2025
Director
Sold on a plan
1,547
$14.28K
6.0%
NTLA
Intellia Therapeutics, Inc.
30 Jun 2025
Director
Sold on a plan
1,547
$14.79K
5.6%
2 decisions on file.
